| Title |
Refractory and Super-Refractory Status Epilepticus—an Update
|
|---|---|
| Published in |
Current Neurology and Neuroscience Reports, April 2014
|
| DOI | 10.1007/s11910-014-0452-x |
| Pubmed ID | |
| Authors |
Sara Hocker, William O. Tatum, Suzette LaRoche, W. David Freeman |
| Abstract |
Status epilepticus is a medical emergency with a high mortality. Early recognition and initiation of treatment leads to a better response and may improve outcomes. Refractory status epilepticus is defined as recurrent seizure activity despite two appropriately selected and dosed antiepileptic drugs including a benzodiazepine. The term "super-refractory status epilepticus" was introduced during the London-Innsbruck Colloquium on status epilepticus in 2011 and refers to status epilepticus that continues or recurs 24 h or more after the initiation of treatment with anesthetic antiepileptic drugs. This includes cases in which seizure control is attained after induction of anesthesia but recurs on weaning the patient off the anesthetic agent. This article reviews the approach to refractory status epilepticus and super-refractory status epilepticus, including management as well as common pathophysiological causes of these entities. |
Mendeley readers
The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Brazil | 2 | 1% |
| Switzerland | 1 | <1% |
| Spain | 1 | <1% |
| Mexico | 1 | <1% |
| Unknown | 168 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 31 | 18% |
| Researcher | 27 | 15% |
| Student > Postgraduate | 23 | 13% |
| Student > Master | 13 | 7% |
| Student > Bachelor | 12 | 7% |
| Other | 35 | 20% |
| Unknown | 34 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 104 | 59% |
| Neuroscience | 15 | 9% |
| Agricultural and Biological Sciences | 7 | 4% |
| Nursing and Health Professions | 3 | 2% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Other | 4 | 2% |
| Unknown | 39 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2014.
All research outputs
#5,874,046
of 22,763,032 outputs
Outputs from Current Neurology and Neuroscience Reports
#307
of 914 outputs
Outputs of similar age
#55,030
of 227,018 outputs
Outputs of similar age from Current Neurology and Neuroscience Reports
#3
of 16 outputs
Altmetric has tracked 22,763,032 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 914 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,018 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.